Mielczarek, Lidia <br/><br/>
In the triple-negative breast cancer MDA-MB-231 cell line, sulforaphane enhances the intracellular accumulation and anticancer action of doxorubicin encapsulated in liposomes.  [electronic resource] 

 -  International journal of pharmaceutics  Mar 2019 
 - 311-318 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-3476 
<br/><br/><label>Standard No.: </label>10.1016/j.ijpharm.2019.01.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibiotics, Antineoplastic--administration & dosage<br/>Anticarcinogenic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Doxorubicin--administration & dosage<br/>Drug Synergism<br/>Female<br/>Humans<br/>Isothiocyanates--administration & dosage<br/>Liposomes<br/>Sulfoxides<br/>Triple Negative Breast Neoplasms--drug therapy